Differentiating Alzheimer disease-associated aggregates with small molecules.
about
Untangling tau imagingInsight into the Molecular Imaging of Alzheimer's DiseaseStructural determinants of Tau aggregation inhibitor potencyA high-throughput screening assay for determining cellular levels of total tau protein.A robotic platform for quantitative high-throughput screeningProbing small molecule binding to amyloid fibrils.Affinity imaging mass spectrometry (AIMS): high-throughput screening for specific small molecule interactions with frozen tissue sections.Synthesis and in vitro evaluation of α-synuclein ligands.Design, Synthesis, and Characterization of 3-(Benzylidene)indolin-2-one Derivatives as Ligands for α-Synuclein Fibrils.Ligand electronic properties modulate tau filament binding site densityModulation and detection of tau aggregation with small-molecule ligandsSmall-molecule mediated neuroprotection in an in situ model of tauopathy.Structure-activity relationship of cyanine tau aggregation inhibitors.Identification of aminothienopyridazine inhibitors of tau assembly by quantitative high-throughput screening.Tau Positron Emission Tomography Imaging.QSAR studies for prediction of cross-β sheet aggregate binding affinity and selectivityInhibitory effect of corcin on aggregation of 1N/4R human tau protein in vitro.Detection and Quantification Methods for Fibrillar Products of In Vitro Tau Aggregation Assays.Novel PET/SPECT probes for imaging of tau in Alzheimer's disease.
P2860
Q26739091-29E16960-5102-4051-914B-4EBCCAE0CE38Q26765945-D1633A79-052E-4D75-AF19-47C960F0AAEFQ30353954-D70972B3-3DA6-457B-8508-E2AE3C8044A7Q31125694-3466BA87-59C9-4573-B925-C829091EEFEFQ33387376-E9D78AE7-8D33-4128-BB8E-93CA897AE4F8Q34050053-CCE2162A-82DB-4205-A33C-EC55126F426FQ35771961-827C3A47-6DA7-47F1-A4A9-4878485C11BDQ36106447-CE1F13C1-5AE6-4084-8E16-15FDB434642DQ36218847-1655F1D6-2BF7-4109-B7EC-BAF7A9961C96Q36368413-F6FCA1D5-7637-46DC-8321-8FBA7DD48E41Q37050216-06C48734-01B8-45C4-A3FB-C33422B24D18Q37087223-36DC0270-8E51-4BD7-9D34-3345638C7338Q37349368-237918F2-1B3D-4222-B274-5B9CFE513B3AQ37412951-C1FF78E8-8886-4F7A-B7E1-6717752AB53AQ39035462-6EF98E42-4406-45D4-8280-E811587294A6Q40998017-BEEBC452-47C4-44D7-BB13-B83BE90985C2Q42414528-4B17B760-F9C5-4742-A0FA-BCB3767B9201Q51263482-284B1E61-53A2-44C0-AEED-92105D600AF8Q53014962-C779D795-A34A-487F-A55F-DA7525CF0E7A
P2860
Differentiating Alzheimer disease-associated aggregates with small molecules.
description
2007 nî lūn-bûn
@nan
2007 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Differentiating Alzheimer disease-associated aggregates with small molecules.
@ast
Differentiating Alzheimer disease-associated aggregates with small molecules.
@en
Differentiating Alzheimer disease-associated aggregates with small molecules.
@nl
type
label
Differentiating Alzheimer disease-associated aggregates with small molecules.
@ast
Differentiating Alzheimer disease-associated aggregates with small molecules.
@en
Differentiating Alzheimer disease-associated aggregates with small molecules.
@nl
prefLabel
Differentiating Alzheimer disease-associated aggregates with small molecules.
@ast
Differentiating Alzheimer disease-associated aggregates with small molecules.
@en
Differentiating Alzheimer disease-associated aggregates with small molecules.
@nl
P2093
P2860
P1476
Differentiating Alzheimer disease-associated aggregates with small molecules.
@en
P2093
James Inglese
Jeff Kuret
Nicolette S Honson
Ronald L Johnson
Wenwei Huang
P2860
P304
P356
10.1016/J.NBD.2007.07.018
P577
2007-07-28T00:00:00Z